Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01111058
Title Everolimus Versus Placebo in Head and Neck Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Chicago
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Miami Miami Florida 33136 United States Details
Northwestern University Chicago Illinois 60611 United States Details
University of Illinois-Chicago Chicago Illinois 60612 United States Details
The University of Chicago Medical Center Chicago Illinois 60637 United States Details
Ingalls Cancer Research Center Harvey Illinois 60426 United States Details
University of Kansas Kansas City Kansas 66160 United States Details
Louisianna State University Shreveport Louisiana 71130 United States Details
Tufts Medical Center Boston Massachusetts 02111 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
University of Minnesota Minneapolis Minnesota 55455 United States Details
University of Mississippi Jackson Mississippi 39216 United States Details
Washington University Saint Louis Missouri 63110 United States Details
University of North Carolina Chapel Hill North Carolina 27599 United States Details
Ohio State University Columbus Ohio 43210 United States Details
Medical University of South Carolina Hollings Cancer Center Charleston South Carolina 29425 United States Details
Vanderbilt University Nashville Tennessee 37232 United States Details
The University of Texas Medical Branch at Galveston Galveston Texas 77555 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field